|
DE3379404D1
(en)
*
|
1982-12-29 |
1989-04-20 |
Kureha Chemical Ind Co Ltd |
Cephalosporin derivatives
|
|
CA2031927A1
(en)
|
1989-12-27 |
1991-06-28 |
Imperial Oil Limited |
Method for improving the activity maintenance of a plasma initiator
|
|
FI922347L
(fi)
|
1990-01-05 |
1992-05-22 |
Pfizer |
Azaoxindolderivat.
|
|
US5112820A
(en)
*
|
1990-03-05 |
1992-05-12 |
Sterling Drug Inc. |
Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
|
|
GB9109246D0
(en)
|
1991-04-30 |
1991-06-19 |
Ici Plc |
Nitrogen derivatives
|
|
DE4129603A1
(de)
|
1991-09-06 |
1993-03-11 |
Thomae Gmbh Dr K |
Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
TW263504B
(enExample)
|
1991-10-03 |
1995-11-21 |
Pfizer |
|
|
FR2692575B1
(fr)
*
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
US5468757A
(en)
|
1994-01-31 |
1995-11-21 |
Eli Lilly And Company |
6-azaindole thromboxane synthase inhibitors
|
|
JPH09509179A
(ja)
|
1994-02-18 |
1997-09-16 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
２−ヘテロアリール−５，１１−ジヒドロ−６Ｈ−ジピリド［３，２−ｂ：２’，３’−ｅ］［１，４］ジアゼピン類及びＨＩＶ感染の予防又は処置におけるそれらの使用
|
|
GB9420521D0
(en)
|
1994-10-12 |
1994-11-30 |
Smithkline Beecham Plc |
Novel compounds
|
|
US5589482A
(en)
|
1994-12-14 |
1996-12-31 |
Pfizer Inc. |
Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
|
|
JPH0920779A
(ja)
|
1995-05-01 |
1997-01-21 |
Japan Tobacco Inc |
縮合ヘテロ５員環アゼピン化合物類及びその医薬用途
|
|
GB9610811D0
(en)
|
1996-05-23 |
1996-07-31 |
Pharmacia Spa |
Combinatorial solid phase synthesis of a library of indole derivatives
|
|
US6696448B2
(en)
|
1996-06-05 |
2004-02-24 |
Sugen, Inc. |
3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
|
|
US6184235B1
(en)
|
1996-08-14 |
2001-02-06 |
Warner-Lambert Company |
2-phenyl benzimidazole derivatives as MCP-1 antagonists
|
|
TWI242011B
(en)
|
1997-03-31 |
2005-10-21 |
Eisai Co Ltd |
1,4-substituted cyclic amine derivatives
|
|
ATE292623T1
(de)
|
1997-05-07 |
2005-04-15 |
Sugen Inc |
2-indolinonderivate als modulatoren der proteinkinase-ativität
|
|
ATE237023T1
(de)
|
1998-01-23 |
2003-04-15 |
Voith Paper Patent Gmbh |
Verfahren zur entfernung von feinen verunreinigungen aus einer faserstoffsuspension
|
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
US6525072B1
(en)
|
1998-08-31 |
2003-02-25 |
Sugen, Inc. |
Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
|
|
GB9904995D0
(en)
|
1999-03-04 |
1999-04-28 |
Glaxo Group Ltd |
Substituted aza-oxindole derivatives
|
|
WO2000053181A1
(en)
|
1999-03-10 |
2000-09-14 |
Merck & Co., Inc. |
6-azaindole compounds as antagonists of gonadotropin releasing hormone
|
|
JP2002538205A
(ja)
|
1999-03-10 |
2002-11-12 |
メルク エンド カムパニー インコーポレーテッド |
性腺刺激ホルモン放出ホルモン拮抗薬としての６−アザインドール化合物
|
|
CA2367116A1
(en)
|
1999-03-10 |
2000-09-14 |
Merck & Co., Inc. |
6-azaindole compounds as antagonists of gonadotropin releasing hormone
|
|
AU3868500A
(en)
|
1999-03-10 |
2000-09-28 |
Merck & Co., Inc. |
6-azaindole compounds as antagonists of gonadotropin releasing hormone
|
|
EP1171125A1
(en)
|
1999-03-10 |
2002-01-16 |
Merck & Co., Inc. |
6-azaindole compounds as antagonists of gonadotropin releasing hormone
|
|
AU3514200A
(en)
|
1999-03-10 |
2000-09-28 |
Merck & Co., Inc. |
6-azaindole compounds as antagonists of gonadotropin releasing hormone
|
|
EP1181296A1
(en)
|
1999-06-03 |
2002-02-27 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
BR9916746A
(pt)
|
1999-06-03 |
2005-01-11 |
Abbott Lab |
Compostos anti-inflamatórios que inibem adesão de célula
|
|
EP1254115A2
(en)
|
2000-02-11 |
2002-11-06 |
Bristol-Myers Squibb Company |
Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
|
|
US20020061892A1
(en)
|
2000-02-22 |
2002-05-23 |
Tao Wang |
Antiviral azaindole derivatives
|
|
EP1132389A1
(en)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
New aza-indolyl derivatives for the treatment of obesity
|
|
GEP20063751B
(en)
|
2000-04-28 |
2006-02-27 |
Baxter Healthcare Sa |
2-Acyl Indol Derivatives and Their Use as Anti-Tumour Agents
|
|
BR0110420A
(pt)
|
2000-04-28 |
2003-07-01 |
Acadia Pharm Inc |
Agonistas muscarìnicos
|
|
DE60119124T2
(de)
|
2000-08-14 |
2006-11-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituierte pyrazole
|
|
US7332494B2
(en)
|
2000-08-14 |
2008-02-19 |
Janssen Pharmaceutica, N.V. |
Method for treating allergies using substituted pyrazoles
|
|
US7342016B2
(en)
|
2000-08-30 |
2008-03-11 |
Schering Corporation |
Farnesyl protein transferase inhibitors as antitumor agents
|
|
EP1315741A2
(en)
|
2000-09-06 |
2003-06-04 |
Ortho-McNeil Pharmaceutical, Inc. |
A method for treating allergies
|
|
AU2001288731B8
(en)
|
2000-09-06 |
2006-04-13 |
Ortho-Mcneil Pharmaceutical, Inc. |
A method for treating allergies using substituted pyrazoles
|
|
EP1324985A4
(en)
|
2000-10-02 |
2004-10-06 |
Merck & Co Inc |
PRENYL PROTEIN TRANSFERASE INHIBITORS
|
|
IL156776A0
(en)
|
2001-01-17 |
2004-02-08 |
Amura Therapeutics Ltd |
Inhibitors of cruzipain and other cysteine proteases
|
|
WO2002062423A1
(en)
|
2001-02-02 |
2002-08-15 |
Bristol-Myers Squibb Company |
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
|
|
US20030207910A1
(en)
|
2001-02-02 |
2003-11-06 |
Tao Wang |
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
|
|
EP1377549A1
(en)
|
2001-03-12 |
2004-01-07 |
Millennium Pharmaceuticals, Inc. |
Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
|
|
PT1385823E
(pt)
|
2001-04-09 |
2007-01-31 |
Novartis Vaccines & Diagnostic |
Compostos de guanidino como agonistas do receptor de melanocortina-4 (r-mc4)
|
|
DE60217669D1
(de)
|
2001-05-14 |
2007-03-08 |
Bristol Myers Squibb Co |
Substitutierte pyrazinone, pyridine und pyrimidine als corticotropin-releasing-factor liganden
|
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
|
US20040235867A1
(en)
|
2001-07-24 |
2004-11-25 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
|
DE10143079A1
(de)
|
2001-09-03 |
2003-05-15 |
Zentaris Ag |
Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel
|
|
WO2003022214A2
(en)
|
2001-09-06 |
2003-03-20 |
Millennium Pharmaceuticals, Inc. |
Piperazine and homopiperazine compounds
|
|
DE60216952T2
(de)
|
2001-10-19 |
2007-07-05 |
Transtech Pharma Inc. |
Beta-carbolin-derivate als ptp-inhibitoren
|
|
DE10152306A1
(de)
|
2001-10-26 |
2003-07-24 |
Asta Medica Ag |
2-Acylindolderivate mit neuen therapeutisch wertvollen Eigenschaften
|
|
TW200301251A
(en)
|
2001-12-20 |
2003-07-01 |
Wyeth Corp |
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
|
|
US20030236277A1
(en)
|
2002-02-14 |
2003-12-25 |
Kadow John F. |
Indole, azaindole and related heterocyclic pyrrolidine derivatives
|
|
AU2003226724A1
(en)
|
2002-03-27 |
2003-10-08 |
Glaxo Group Limited |
Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
|
|
EP1495016A2
(en)
|
2002-04-09 |
2005-01-12 |
Astex Technology Limited |
Heterocyclic compounds and their use as modulators of p38 map kinase
|
|
US20040063744A1
(en)
|
2002-05-28 |
2004-04-01 |
Tao Wang |
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
|
|
UA78999C2
(en)
|
2002-06-04 |
2007-05-10 |
Wyeth Corp |
1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
|
|
US6900206B2
(en)
|
2002-06-20 |
2005-05-31 |
Bristol-Myers Squibb Company |
Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
|
|
TW200403243A
(en)
|
2002-07-18 |
2004-03-01 |
Wyeth Corp |
1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
|
|
AU2003246972A1
(en)
|
2002-08-06 |
2004-02-23 |
Astrazeneca Ab |
Condensed pyridines and pyrimidines with tie2 (tek) activity
|
|
ES2273077T3
(es)
|
2002-08-21 |
2007-05-01 |
Glaxo Group Limited |
Derivados de 2-fenilamino-4-trifluorometil-5 (bencil- o piridin-4-il-metil) carbamoilpirimidina como moduladores selectivos del receptor cannabinoide cb2.
|
|
GB0222493D0
(en)
|
2002-09-27 |
2002-11-06 |
Glaxo Group Ltd |
Compounds
|
|
NZ538457A
(en)
|
2002-09-30 |
2008-04-30 |
Genelabs Tech Inc |
Nucleoside derivatives for treating hepatitis C virus infection
|
|
FR2845388B1
(fr)
|
2002-10-08 |
2004-11-12 |
Sanofi Synthelabo |
Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
|
|
JP2006517966A
(ja)
|
2003-02-14 |
2006-08-03 |
ワイス |
５−ヒドロキシトリプタミン−６リガンドとしてのヘテロサイクリル−３−スルホニルアザインドールまたは−アザインダゾール誘導体
|
|
US20040214856A1
(en)
|
2003-04-23 |
2004-10-28 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
|
ATE412651T1
(de)
|
2004-06-09 |
2008-11-15 |
Glaxo Group Ltd |
Pyrrolopyridinderivate
|